Navigation Links
How Long Will the Economic Downturn Affect the Dental Biomaterials Market?
Date:3/24/2009

eohealth, RIEMSER Arzneimittel (incl. Curasan), RTI Biologics, Straumann, and many more.

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry
2. Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference
3. Life Science Labs Reacting to the Economic Crisis
4. Despite Economic Woes, Physician Compensation Increases
5. Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22
6. Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
7. Histogen Featured on Economic Report Television Series
8. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
9. North Carolinas Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
10. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
11. OncoGenex increases economic interest in lead cancer drug OGX-011
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign 2Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 2Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 3Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 4Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 5Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 6Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 7Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 8Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 9Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 10Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 11Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 12Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 13Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 14Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share 15
Breaking Biology News(10 mins):A window that washes itself? 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 1Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 2Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 3Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 4Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 5Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 6Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 7Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 8Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 9Orexigen 28R 29 Therapeutics Announces Third Quarter 2009 Financial Results 5987 10PSA Reading Could Predict Post Radiation Survival 60702 1PSA Reading Could Predict Post Radiation Survival 60702 2Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 1Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 2